Total Valuation
Pharmaust Limited has a market cap or net worth of €36.66M. The enterprise value is €36.12.
Market Cap€36.66M
Enterprise Value€36.12
Share Statistics
Pharmaust Limited has 791,652,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding791,652,340
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmaust Limited’s return on equity (ROE) is -0.84 and return on invested capital (ROIC) is -68.44%.
Return on Equity (ROE)-0.84
Return on Assets (ROA)-0.45
Return on Invested Capital (ROIC)-68.44%
Return on Capital Employed (ROCE)-2.18
Revenue Per Employee488.49K
Profits Per Employee-297.86K
Employee Count36
Asset Turnover0.74
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pharmaust Limited is ―. Pharmaust Limited’s PEG ratio is 0.06.
PE Ratio―
PS Ratio2.08
PB Ratio2.87
Price to Fair Value2.87
Price to FCF-2.43
Price to Operating Cash Flow-3.77
PEG Ratio0.06
Income Statement
In the last 12 months, Pharmaust Limited had revenue of 17.59M and earned -10.72M in profits. Earnings per share was -0.02.
Revenue17.59M
Gross Profit17.59M
Operating Income-27.76M
Pretax Income-27.08M
Net Income-10.72M
EBITDA-27.75M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -15.07M and capital expenditures -8.22K, giving a free cash flow of -15.08M billion.
Operating Cash Flow-15.07M
Free Cash Flow-15.08M
Free Cash Flow per Share-0.02
Dividends & Yields
Pharmaust Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-47.89%
50-Day Moving Average0.03
200-Day Moving Average0.04
Relative Strength Index (RSI)80.10
Average Volume (3m)0.00
Important Dates
Pharmaust Limited upcoming earnings date is Mar 3, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Pharmaust Limited as a current ratio of 2.16, with Debt / Equity ratio of 26.02%
Current Ratio2.16
Quick Ratio2.16
Debt to Market Cap0.09
Net Debt to EBITDA0.34
Interest Coverage Ratio-37.65
Taxes
In the past 12 months, Pharmaust Limited has paid -16.36M in taxes.
Income Tax-16.36M
Effective Tax Rate0.60
Enterprise Valuation
Pharmaust Limited EV to EBITDA ratio is -0.98, with an EV/FCF ratio of -1.80.
EV to Sales1.55
EV to EBITDA-0.98
EV to Free Cash Flow-1.80
EV to Operating Cash Flow-1.80
Balance Sheet
Pharmaust Limited has €12.71M in cash and marketable securities with €3.31M in debt, giving a net cash position of €9.40M billion.
Cash & Marketable Securities€12.71M
Total Debt€3.31M
Net Cash€9.40M
Net Cash Per Share€0.01
Tangible Book Value Per Share€0.02
Margins
Gross margin is 0.00%, with operating margin of -157.83%, and net profit margin of -60.98%.
Gross Margin0.00%
Operating Margin-157.83%
Pretax Margin-154.01%
Net Profit Margin-60.98%
EBITDA Margin-157.82%
EBIT Margin-157.83%
Analyst Forecast
The average price target for Pharmaust Limited is €0.12, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€0.12
Price Target Upside209.06% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast48.74%